International Journal of General Medicine (Jul 2022)

Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis

  • Setiawan B,
  • Budianto W,
  • Sukarnowati TW,
  • Rizky D,
  • Pangarsa EA,
  • Santosa D,
  • Setiabudy RD,
  • Suharti C

Journal volume & issue
Vol. Volume 15
pp. 6215 – 6226

Abstract

Read online

Budi Setiawan,1 Widi Budianto,1 Tri Wahyu Sukarnowati,1 Daniel Rizky,1 Eko Adhi Pangarsa,1 Damai Santosa,1 Rahajuningsih Dharma Setiabudy,2 Catharina Suharti1 1Hematology-Medical Oncology Division, Internal Medicine Department, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia; 2Clinical Pathology Department, Faculty of Medicine, University of Indonesia, Jakarta, IndonesiaCorrespondence: Budi Setiawan, Hematology-Medical Oncology Division, Internal Medicine Department, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Jl. Dr. Soetomo No. 16, Semarang, Indonesia, Email [email protected]: Deep vein thrombosis (DVT) is a common complication and the second leading cause of death in cancer patients. Pro-inflammatory stimuli in the cancer microenvironment induce nuclear factor kappa B (NF-κB) signaling pathway that plays an integral role in immunothrombosis mechanism.Objective: To investigate the role of inflammatory and coagulation biomarkers in the development of DVT in cancer patients with high risk of thrombosis (Khorana score ≥ 2).Subjects and methods: This study was a cross-sectional study at Dr. Kariadi General Hospital. The serum levels of proinflammatory cytokines, ie, NF-κB, interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and coagulation biomarkers, ie, tissue factor (TF), prothrombin fragment F1+2 (F1+2), fibrinogen and D-dimer were measured in newlydiagnosed cancer patients with a highrisk of thrombosis. Color duplex sonography was used for DVT screening.Results: From January to November 2021, there were 83 eligible patients. DVT was confirmed in 8 subjects (9.63%). Univariate analysis revealed a significant difference between the median age of patients with DVT compared to non-DVT patients, 49.5 years (range: 23– 60 years) and 42 years (range: 19– 60 years), with p=0.046. D-dimer level was higher in DVT patients [(6.020 μg/L, range 2.090– 20.000) vs (1.940 μg/L, range 270– 20.000), p=0.005]. Multivariate analysis revealed age and D-dimer were significantly correlated with DVT incidence. In all patients, there were significant positive correlations between several inflammatory and coagulation activation parameters, which were IL-6 with D-dimer and F1+2, CRP with F1+2 and D-dimer as well as TNF-α with F1+2. However, these findings were not shown in DVT patients.Conclusion: In cancer patients with a high risk of thrombosis, age and D-dimer level are the significant variables towards the incidence of DVT. In patients with DVT, there was no significant correlation between inflammatory and coagulation activation parameters.Keywords: inflammation, activation of coagulation, DVT, high-risk thrombosis, cancer patients

Keywords